Your ticket for Medtech Rising gives you access to two days of world class speakers and a place at the Irish Medtech Excellence Awards gala

Medtech Rising 2018 will bring together the world’s leading business leaders and international experts on, delivering better health outcomes, new technologies and cross-sector collaboration, innovation and growing product portfolios. Delegates will enjoy unmissable networking opportunities to connect with as many as 500 medtech professionals. This global conference for Ireland provides unrivalled access to experts and industry trends making it unmissable for senior medtech professionals.

Day 1

5 Dec 2018

On day 1 business leaders and experts will explore:

  • Rethinking what it means to bring value to healthcare and the impact on innovation and coverage.
  • Product adoption and clinical research in Ireland and the ecosystem to support same.
  • Leading international physician perspectives on the application of new technologies, including 3D, advanced robotics, AI and neurotechnology in a clinical setting to drive efficiency in surgery.
  • Global clinical – industry collaboration models: A partnership for innovation. International models of success, and industry case studies.
  • Globalization of R&D and opportunities to increase the ambition and level medtech R&D in Ireland
  • Irish Medtech Association AGM

Day 2

6 Dec 2018

On day 2 business leaders and experts will explore:

  • Global leaders perspective on the global medtech business model of the future: M&A, Solutions, Value, Partnering and more.
  • Trade Wars, Brexit and the evolution of the global political and economic landscape: How Ireland is responding and what it means for your business
  • The convergence of sectors to deliver more personalised healthcare and customer engagment of the future, a perspective from tech giants to early stage medtech innovators
  • Investment strategies for medtech: The power of value in fundraising, what VCs are looking for and personal insights from both seasoned and early stage entrepreneurs.

Day 1: Wednesday 05 December


Registration & Networking Breakfast




Welcome Address: David Tallon, Vice President, R&D, Neuro, Spine, ENT & Navigation, Stryker

Session 1: Rethinking what it means to bring value to healthcare

This session will help professionals understand how innovation is adding value in medtech and how this is measured in patient outcomes, rather than short term costs. This is part of major paradigm shift in medtech as industry moves away from developing products to solutions that adds value to patients and health systems. The implications of this shift, is that today payers and providers are evaluating medical technologies not only on the bases of safety and efficacy, but also by measuring cost utility. Medtech companies need to fundamentally rethink what it means to bring value to healthcare and become smarter about the pain points and clinical, economic, and operational outcomes that their customers care about. This session will provide global perspectives from both an industry and physician perspectives about how value-based care is shaping medtech and what this means for innovation in business and for patients.  


Anna Rafferty, Head of Market Access and External Affairs, Janssen


Dr Douglas D. Backous, MD, FACS, Swedish Neuroscience Institute Seattle, Washington


Joseph Rolley, Vice President, Reimbursement & Market Access, Integra Life Sciences



Session 2: Supporting clinical research and product adoption in the Irish healthcare system

A world class clinical and academic research ecosystem is a critical part of any global medtech research ecosystem. This panel comprises of leaders from organisation underpinning innovation in the Irish ecosystem, including; Clinical Research Development Ireland (CRDI), Health Innovation Hub, and the Health Service Executive. Lean what supports are currently available to support academic or clinical collaboration in Ireland and the future strategic direction and ambition to support more adoption and creation of innovation here.  The Health Innovation Hub Ireland (HIHI) works across the health sector with Irish businesses to creatively solve problems and improve patient care. Harnessing this innovation, through development of new healthcare technologies, products, and services. The mission of Clinical Research Development Ireland (CRDI) is to advance patient care and health service delivery by supporting the development of clinical and translational research across  partner academic institutions,  medical schools and associated hospitals. 


Dr Tanya Mulcahy, National Manager, Health Innovation Hub Ireland  


Panel Discussion:

  • Prof. Helen Whelton, Head of the College of Medicine and Health, UCC and Chief Academic Officer to the HSE South West Hospital Group.
  • Dr Pat O’Mahony, CEO, Clinical Research Development Ireland


Tea/Coffee & Networking

Session 3: The application of new technologies, including 3D and robotics in a clinical setting to drive efficiency in surgery.  

Featuring leading global physician thought leaders, this session will discuss how innovation is fuelling efficiencies in surgery process, driving disruption and leading to better patient outcomes. With as many as 4,000 surgical robots across the world’s hospitals and 54% of global healthcare executives predicting that AI will be used in medical decision support in the next few years there is an opportunity to build on this and be at the vanguard of connected health. From advanced robotics, to additive manufacturing to cutting edge neurotechnology, we’re excited to have global clinical experts discuss the implications for manufacturers and patients and how technology is transforming surgery and healthcare in general.


Mag O Keeffe, Director Operations, Plant Manager, Additive Manufacturing, Stryker


Dr Garnette Sutherland, Professor, Department of Clinical Neurosciences, University of Calgary, Canada


Mr Cellan Thomas, Maxiollofacial Surgeon, University Hospital of Wales


Prof. Barry O’Reilly, Consultant in Obstetrics and Gynaecology, Cork University Maternity Hospital




Networking Lunch

Session 4: Global clinical – industry collaboration models: A partnership for innovation  

Collaboration has been the driving force behind the growth of many industries and medtech is no exception. It is, after all, a direct result of the collaboration between medical research and industry, encompassing health investors, SMEs and manufacturers. Industry-Clinical collaboration is a core partnership for medtech innovation.  From research, development, prototyping, clinical investigations, commercialisation, training to new idea generation, the relationship is key.  Hear from a leading consultant about how access to KOL’s and the presence of leading clinical research institutions is a critical component for global medtech R&D ecosystems, along with examples of collaborative models and R&D strategies within the sector which are driving the generation of next medtech development.


Teresa Glynn, Director Customer Engagement & Communications, Medtronic


Jeroen de Kempenaer, Senior, Philips Innovation Services


Neil Davis, Senior Director, Strategic Capabilities, Johnson & Johnson


John McNamara, VICE President, Research & Development, Medtronic




Tea/Coffee networking break

Session 5: Globalization of R&D and opportunities to increase the ambition and level medtech R&D in Ireland

Innovation is at the heart of the medtech sector, and medtech is perhaps the most innovative sector, with over 13,000 patents filed in the EU last year. A thriving R&D ecosystem that can continuously reinvent itself is critical and becoming a centre of excellence for R&D and winning more corporate R&D portfolios is a strategic objective under the Irish Medtech Association Strategy to 2020. As such,  the Irish Medtech Association has commissioned Technopolis Consultancy to support the development of a strategy to increase the R&D intensity of the Irish medtech sector. The decision on the location factors for R&D is driven by the interplay of various factors, that can be classified into three groups; parent company strategies, subsidiary potential and host country characteristics. In this session, Technopolis will discuss the locations factors that are relevant to the Irish Medtech Ecosystem, and we will hear how two companies have positioned themselves successfully to win more global R&D.


Chair & brief presentation; Geert van der Veen, Director, Technopolis |group| The Netherlands


Mark Hennessy, Site Lead, Bausch + Lomb






Closing Remarks



Irish Medtech Association AGM & Drinks Reception

Open to delegates of the conference (non-members cannot vote)

The chair, vice chair and director of the Irish Medtech Association will provide members of the Irish Medtech Association an update on some of the key campaigns the sector has been working on over the past 12 months and plans for the year ahead.  Our board, working groups and senior business leaders have taken time out of their busy schedules and devoted it to the interests of the industry as a whole. We know that working together, be sharing the sectors combined expertise we can ensure we can continue to complete in an ever-changing global marketplace.


AGM Panel Speakers

  • David Tallon, Vice President, R&D, Neuro, Spine, ENT & Navigation, Stryker
  • Conor Hanley, CEO, FIRE 1
  • Sinead Keogh, Director, Irish Medtech Association


Evening Reception


Day 1 Close

Day 2: Thursday, 06 December


Registration & Networking Breakfast


Welcome Address: David Tallon, Vice President, R&D, Neuro, Spine, ENT & Navigation, Stryker

Session 6: Trade Wars, Brexit and the evolution of the global political and economic landscape: How Ireland is responding and what it means for your business.

This session offer insight into opportunities and challenges for medtech in the wake of Brexit and changing trade and tax policy under US President Trump. Half of Irish Medtech Association member companies said Brexit is expected to lead to greater customs cost and skills shortages and one in four medtech companies identified UK-EU regulatory divergence as a risk. With the risk of Brexit ‘no-deal’ it’s vital that patient access to innovative medical technology is ensure with the mutual recognition of CE marks and guarantees to avoid regulatory divergence which would split the €110 billion European medtech market. Further afield fears remain that tariffs imposed on steel and aluminium will lead to serious effects on medtech and may lead to a trade war with the EU. Globally, the medtech sector has also been impacted by the Trump trade war with China, which has seen a range of retaliation measures over the past 6 month, with up to 25% tariff increase on some products. US tax reform, the prospect of an EU digital sales tax and Irish intellectual property taxation policy are already or have the potential to significantly change the medtech industry landscape. Our distinguished panel will discuss these trends and the global and political environment and touch on some national innovation policies that are helping companies to compete globally, such as the new Disruptive Innovation Fund. Leaders will offer advice on how businesses can prepare to compete in the face of this political and economic uncertainty.


Anton Savage, Journalist


Panel Discussion:

  • Fergal O’Brien, Director of Policy and Public Affairs, Ibec
  • Tom Kelly, Divisional Manager, Cleantech, Electronics and Life Sciences, Enterprise Ireland
  • Mary McGinley, Director, Tax, KPMG Ireland


Tea/Coffee Networking

Session 7: Leaders perspective on the global medtech business model of the future

A decade since the financial crises, the medtech industry has established steady growth rates, and record levels of Venture Capital investment. This session will explore how medtech businesses can keep pace as the global industry undergoes rapid transformation with new trends shaking up markets to drive medtech growth forecast at 5.1% annually to 2022. The medtech industry is now worth €475 billion globally but tapping into the potential for future growth will mean embracing new business models. Market dynamics are changing, with the growing importance of strategic partners, the evolving relationships with health systems, managing global supply chains, as well as implications for financing with shifts in M&As and VC investments deals becoming scarcer but larger. During this session we will get both an FDI multinational perspective and hear what this means for the Irish medtech ecosystem.


Anton Savage, Journalist


Panel Discussion:

  • Dylan Crotty, President, Stryker Instruments Division
  • Jorg Schneewind, President at Bemis Healthcare Packaging, Inc.
  • Rachel Shelly, Head of Medical Technologies, IDA


Networking Lunch

Session 8: The convergence of sectors to deliver more personalised healthcare and customer engagement of the future

The total global economic impact of the Internet of Things (IoT) by 2025 is forecasted to be €6.5 trillion with healthcare expected to contribute the largest single sector value of €2 trillion. With 18 of the world’s top 25 medtech tech companies, 10 of the world’s top 10 ICT companies and nine of the world’s top 10 pharma companies based here, Ireland is uniquely placed to be a world leader in the provision of total connected health solutions.  The Internet of Medical Things (IoMT) is set to improve lives, life expectancy and quality of life. These solutions will connect devices and wearables with the consumer which will generate meaningful data, which will enable informed and continuous care for patients. Consumers expect easy-to-use platforms, high-quality care and secure health and personal information; they also want to keep the human connection with their physician. However, Medtech has yet to fully realise the potential of new digital technologies to transform the industry. Connected Health will capture and analyse data to deliver personalise care and improved outcome, while presenting new challenges in customer engagment, data management and cybersecurity. We will hear how the digital age will impact product adoption and behavioural change.  Digital is a transformative opportunity for healthcare, which is quickly blurring the lines across the traditional healthcare ecosystem. Globally, healthcare systems are adapting to new technologies and new ways of managing health. This session will explore how companies with a tradition in software are making their mark in medtech.


Anton Savage, Journalist


Michael V McConnell, MD, MSEE, Head, Cardiovascular Health Innovations, Verily Life Sciences/Alphabet Inc


Jamie Haggard, CEO/Co-Founder, Green Sun Medical


Dr Frank O’Donnell, Public Sector lead, Microsoft




Tea/Coffee Networking

Session 9: Investment strategies for medtech: The power of value in fundraising, what VCs are looking for and personal insights from both seasoned and early stage entrepreneurs.

To capture scares investment capital and the attention of strategic partners, early-stage companies must demonstrate a compelling value proposition backed by clinical data. Companies that execute a sound reimbursement and commercialising strategy are finding investment to succeed. Hear where venture funding is being invested,  the trends and what investors are looking for. For seasoned entrepreneurs and investors, is experience worth its weight in gold? In an industry full of sophisticated and complex medical technologies, achieving success requires great leadership, vision,  grit and determination. Learn the keys to success from these experienced executives and investors and early stage innovators.


Anton Savage, Journalist


Lisa Suennen, Senior Managing Director at GE Ventures






Joan FitzPatrick, CEO, Kite Medical


Conference Close



Drinks Reception


Awards Dinner


Awards Close


The Rochestown Park Hotel

The Rochestown Park Hotel, formally one of Ireland’s most historical houses, has been meticulously restored and refurbished since 1989 to culminate into an International luxury Hotel & Conference Centre. Standing impressively adjacent to the South Link Road within the prestigious village of Douglas, a mere 5 kilometres from Cork City Centre, Jack Lynch Tunnel and Cork International Airport.
Following a €2.2 million investment in 2015 to renovate bedrooms, conference facilities, function rooms, bar and restaurant the hotel is now one of the premier destinations for conferences in the country. See www.rochestownpark.com for more.

There is Car Parking available at the hotel. However it is subject to availability and on a first come, first served basis. The car park known as the Q Park Railway Carpark is below the hotel but is not operated by the hotel. The car park rate is €2.40 per hour. Hotel residents enjoy a rate of €5 per car per night.

For detailed direction please click here

If you are travelling on Wednesday evening and need accommodation, please note the following hotels which are close to the event:

Maryborough Hotel
5 minute drive from the Rochestown Park Hotel
Room Rate: €185
To book email: reservation@maryboroughhotel.ie

Silver Springs Hotel
13 minute drive from Rochestown Park Hotel
Room Rate: Single €105 B&B, Double €115 B&B (special rate, mention Medtech event to avail of it)
To book contact www.claytonhotelsilversprings.com

Radisson Blu Hotel & Spa, Cork
12 minutes drive from Rochestown Park Hotel
Room rate: 5 December, Single €173 B&B, Double €193 B&B and 6 December Single €118 B&B, Double €138 B&B
To book contact (021) 429 7000 www.radissonblu.com/en/hotel-cork

To avail of a preferential corporate rate, please make your booking through Mustbook.ie at sales@mustbook.ie and quote Ibec Medtech in your booking.



€595 +23% vat


€995 +23% vat

Your ticket for Medtech Rising gives you access to two days of world class speakers and a place at the Irish Medtech Excellence Awards gala on 6 December 2018

Event Hosts
2017 Gallery

Platinum Sponsor

Gold Sponsor

Silver Sponsor

Training Partner

Ibec clg which is registered in Ireland. Registration No. 8706
Registered address: 84/86 Lower Baggot Street Dublin 2 www.ibec.ie
T: (01) 605 1500; E: info@irishmedtechassoc.ie;
W: www.irishmedtechassoc.ie
Privacy Policy